insights_auto
Why is ISI up 3.58%?
Dive Deeperchevron_right
ISI:ETR
Ionis Pharmaceuticals Inc
€40.19
arrow_upward
+3.58%(+1.39) 1D
Oct 20, 5:35:35 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ISI...
Open
€39.42
High
€40.19
Low
€39.42
Mkt. cap
7.48B
Avg. vol.
120.00
Volume
0.00
52-wk high
€75.20
52-wk low
€38.07
No. of employees
1K
Open
€39.42
High
€40.19
Low
€39.42
Mkt. cap
7.48B
Avg. vol.
120.00
Volume
0.00
52-wk high
€75.20
52-wk low
€38.07
No. of employees
1K
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
Severe Hypertriglyceridemia Market Set for Growth During the Forecast Period (2026-2036) Following Approval of Ionis' TRYNGOLZA and Emergence of Novel Therapies | DelveInsight
Investing.com Nigeria
·
17 hours ago
Ionis Pharma EVP Devers sells $59,081 in stock By Investing.com
Investing.com Nigeria
·
17 hours ago
Ionis Pharmaceuticals EVP research Eric Swayze sells $2,307 in stock By Investing.com
Investing.com India
·
1 day ago
InvestingPro Fair Value flagged Ionis stock before 48% plunge By Investing.com
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com